胡芦巴总皂苷降低非酒精性脂肪肝大鼠血脂水平及肝内脂质沉积
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
胡芦巴总皂苷降低非酒精性脂肪肝大鼠血脂水平及肝内脂质沉
积
张瑜;张之;毛新民
【期刊名称】《实用肝脏病杂志》
【年(卷),期】2013(000)006
【摘要】Objective To study the therapeutic effect of trigonella foenum greacum. L saponin(TFGs)on blood lipid and liver lipid deposition in rats with nonalcoholic fatty liver disease. Methods A rat model of high-fat diet induced nonalcoholic fatty liver disease was established. Rsts were then treated with different dosages of TFGs (low,middle and high dose)for 5 weeks. The blood lipids,liver lipid deposition,liver index (ratio of liver weight/body weight)and hepatocyte steatosis were examined. Results The serum total cholesterol (TC)levels de-creased to
(2.72±0.26)mmol/L,(2.69±0.57)mmol/L and
(2.12±0.38)mmol/L,respectively,and the low density lipoprotein-cholesterol(LDL-C)decrea sed to (1.50±0.16)mmol/L,(1.59±0.33)mmol/L and (1.15±0.24)mmol/L,respec-tively,in rats with TFGs intervention at
low,middle and high doses at the end of observation,which were all sig-nificantly lower than that in the non-treated models [TC was
(3.58±1.08)mmol/L,and LDL-C was (1.60±0.18) mmol/L,(P<0.01)];In liver homogenates,TGFs treatment at low,middle and high doses decreased the TC by 67.4%, 66.7% and 63.1%,respectively(P<0.01),decreased the
triglyceride(TG)by 56.0%,42.6% and 52.3%,respectively(P<0.01),and decreased the liver index by 12.1%,9.1% and 6.06%,respectively (P<0.01)as compared to those in non-treated models;Significant remission of steatosis in livers was observed in high TGFs groups by histopathology. Conclusion TFGs could decrease blood lipids and ameliorates liver lipid deposition in rats with high-fat diet induced nonalcoholic fatty liver disease and maybe become a promising remedy for this disorder in human.%目的:观察胡芦巴总皂苷(TFGs)对非酒精性脂肪肝大鼠血脂水平及肝内脂质沉积的影响。
方法建立大鼠高脂饮食非酒精性脂肪肝模型,给予小、中、大剂量TGFs治疗5周后,观察各组血脂、肝内脂质、肝指数和肝细胞脂肪变的变化。
结果在处理后,小、中和大剂量TFGs组血清总胆固醇分别为(2.72±0.26)mmol/L、(2.69±0.57) mmol/L和(2.12±0.38)mmol/L,低密度脂蛋白分
别为(1.50±0.16)mmol/L、(1.59±0.33)mmol/L和(1.15±0.24) mmol/L,较模型对照组总胆固醇为[(3.58±1.08)mmol/L,低密度胆固醇为(1.60±0.18)mmol/L均显著下降(P<0.01)],但三种剂量处理组动物血清甘油三脂水平无显著性变化;与模型组比,小、中和大剂量TGFs组肝组织匀浆总胆固醇分别下降了67.4%、66.7%和63.1%,甘油三脂分别下降了56.0%、42.6%和52.3%
(P<0.01),肝指数分别下降了[(12.1%、9.1%和6.1%(P<0.01)];病理学检
查显示TGFs处理组动物肝细胞脂肪变程度明显降低。
结论 TFGs可降低血脂水平和减少肝内脂质沉积,对高脂饮食诱发的非酒精性脂肪肝有治疗作用。
【总页数】3页(P496-498)
【作者】张瑜;张之;毛新民
【作者单位】830000 乌鲁木齐市新疆维吾尔自治区人民医院高血压科;新疆医科大学药理教研室;新疆医科大学药理教研室
【正文语种】中文
【相关文献】
1.胡芦巴总皂苷对饮食诱导肥胖大鼠糖脂代谢及胰岛素抵抗的影响 [J], 卢芙蓉;秦铀;沈霖;熊鹏程;于丽秀
2.胡芦巴总皂苷抗非酒精性脂肪性肝炎大鼠机制的研究 [J], 张瑜;张龑之;毛新民
3.三七总皂苷对大鼠非酒精性脂肪肝模型胰岛素抵抗及瘦素受体表达的影响 [J], 赵兴国;李丽
4.胡芦巴总皂苷对血脂紊乱模型大鼠生化指标的影响 [J], 孙晓风;李琳琳;毛新民
5.三七总皂苷和多烯磷脂酰胆碱调控大鼠非酒精性脂肪肝的药效学比较 [J], 姜清芳;黄敏怡;游春香;容燮峰;江涛
因版权原因,仅展示原文概要,查看原文内容请购买。